Skip to main content

Open Access Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017

No Abstract

Keywords: bedaquiline; delamanid; multidrug-resistant tuberculosis

Document Type: Research Article

Affiliations: 1: Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA 2: Tuberculosis Department, Partners In Health, Boston, Massachusetts, USA 3: Department of Lung Health, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France 4: Tuberculosis Division, The Union, Paris, France 5: Departments of Epidemiology, Biostatistics and Global Health, Boston University School of Public Health, Boston, Massachusetts, USA, Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

Publication date: September 21, 2018

More about this publication?
  • Public Health Action (PHA), The Union's quarterly Open Access journal, welcomes the submission of articles on operational research. It publishes high-quality scientific research on health services, providing new knowledge on how to improve access, equity, quality and efficiency of health systems and services.

    The Editors will consider any manuscript reporting original research on quality improvements, cost-benefit analysis, legislation, training and capacity building, with a focus on all relevant areas of public health (e.g. infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance, outbreaks etc).

  • Editorial Board
  • Information for Authors
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content